Compare Suncare Traders with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -8.78% CAGR growth in Net Sales over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.90
- The company has been able to generate a Return on Equity (avg) of 1.05% signifying low profitability per unit of shareholders funds
Negative results in Jun 26
Stock DNA
Trading & Distributors
INR 11 Cr (Micro Cap)
25,265,193,909,548,484.00
24
0.00%
0.14
0.00%
0.27
Total Returns (Price + Dividend) 
Suncare Traders for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Suncare Traders Ltd Valuation Shifts Amid Market Challenges
Suncare Traders Ltd, a micro-cap player in the Trading & Distributors sector, has undergone a significant valuation reassessment, shifting from an expensive to a fair valuation grade. Despite this adjustment, the company continues to face severe headwinds, reflected in its dismal share price performance and weak financial metrics compared to peers and broader market benchmarks.
Read full news article
Suncare Traders Ltd Valuation Shifts Highlight Price Attractiveness Concerns
Suncare Traders Ltd, a micro-cap player in the Trading & Distributors sector, has seen a marked shift in its valuation parameters, moving from a fair to an expensive rating. Despite a stagnant share price of ₹0.44, the company’s price-to-earnings (P/E) ratio has surged to an astronomical level, signalling significant market scepticism. This article analyses the valuation changes in the context of peer comparisons, historical returns, and key financial metrics to assess the stock’s price attractiveness.
Read full news article
Suncare Traders Ltd Valuation Shifts: From Expensive to Fair Amid Market Challenges
Suncare Traders Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this adjustment, the company continues to face considerable headwinds, reflected in its steep negative returns over multiple time horizons and a strong sell rating by MarketsMOJO. This article analyses the recent valuation changes, compares key metrics with peers, and assesses the implications for investors.
Read full news article Announcements 
Closure of Trading Window
17-Sep-2026 | Source : BSEPFA
Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
04-Sep-2026 | Source : BSEReg. 34 (1) Annual Report.
04-Sep-2026 | Source : BSEPursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are submitting herewith the Annual Report of the Company for the financial year 2025-26 along with the Notice of 29th Annual General Meeting to be held on Tuesday 29th September2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Suncare Traders Ltd has announced 2:10 stock split, ex-date: 06 Mar 20
Suncare Traders Ltd has announced 2:1 bonus issue, ex-date: 06 Mar 20
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Biogen Pharmachem Industries Limited (4.69%)
Nilmesh Infrabuild Llp (11.78%)
69.05%
Quarterly Results Snapshot (Standalone) - Jun'26 - YoY
YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Jun 2026 is -68.75% vs 500.00% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -633.33% vs 108.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -84.81% vs 241.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
YoY Growth in year ended Mar 2026 is 11.86% vs 51.28% in Mar 2025






